Dr. Richard S. Zimmerman, MD

Dr. Zimmerman practices at Mayo Clinic Ambulatory Surgery Center - Scottsdale in Scottsdale, Arizona.

Dr. Zimmerman's NPI, 1780669937, was assigned on December 9, 2005. Dr. Zimmerman graduated from Boston University School Of Medicine in 1983. Dr. Zimmerman holds Arizona license 18607.

Dr. Zimmerman's primary practice is Mayo Clinic Ambulatory Surgery Center - Scottsdale, at 13400 East Shea Boulevard, Scottsdale, AZ 85259. The practice phone is (480) 342-4201.

Dr. Zimmerman's primary practice is Mayo Clinic Ambulatory Surgery Center - Scottsdale in Scottsdale, Arizona. Dr. Zimmerman is also affiliated with Mayo Clinic Hospital - Phoenix. The medical group on file is Mayo Clinic Arizona. Dr. Zimmerman's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zimmerman practices, 2 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Zimmerman's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Zimmerman is board certified in neurological surgery by the American Board of Neurological Surgery. Dr. Zimmerman is licensed in Arizona.

Dmand AI lists back and neck pain treatment without fusion, craniotomy, lower back pain, muscle pain, fibromyalgia, and limb pain, neck pain and spine problems, spinal fusion and thoracic spine disorders among the conditions Dr. Zimmerman treats.

CMS data shows 452 Medicare services from Dr. Zimmerman across 11 procedure codes in 2024, for 287 Medicare patients. Medicare paid $96,756 for them.

CMS counts 287 Medicare patients who saw Dr. Zimmerman in 2024. The largest group is 65 to 74, with 145 patients. 74% of them have high cholesterol, and 70% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Zimmerman's median patient age at 69, with 71% women.

In 2024, Dr. Zimmerman wrote 15 Medicare Part D claims for 12 patients. 87% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $169 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Zimmerman for performance year 2024, reported as part of a group. Dr. Zimmerman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zimmerman as offering telehealth.

Dmand AI links 78 papers to Dr. Zimmerman, published from 2007 to 2025. 2021 was the busiest year, with 4. The most frequent topics are Magnetic Resonance Imaging, Brain Neoplasms and Electric Stimulation Therapy. Dr. Zimmerman has published most often in J Neurosurg. Dr. Zimmerman's most frequent co-authors are Bernard R. Bendok, MD, Joseph I. Sirven, MD and Chandan Krishna, MD.

Dmand AI links Dr. Zimmerman to 2 clinical trials. Conditions studied include Seizures and Epilepsy. NeuroPace sponsors the most, 2.

CMS Open Payments shows 87 general payments to Dr. Zimmerman from 7 drug and device companies from 2016 to 2023. Travel and lodging make up the largest share, 30% of the total. Medtronic USA, Inc. paid the most, $11,027.

Dmand AI lists 4 awards for Dr. Zimmerman, most recently Mayo Distinguished Educator in 2022. Dr. Zimmerman serves on MCA Education Committee.

Dr. Zimmerman graduated from Boston University School Of Medicine in 1983. Dr. Zimmerman is a member of AANS and CNS.

Dr. Zimmerman is in network with 4 carriers, including Excellus BlueCross BlueShield, United Healthcare and Blue Cross and Blue Shield of Kansas City. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.